Study on the Effect of Acupoint Massage Combined with Auricular Acupressure in Preventing and Treating Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

INTERVENTION: Control Group:Received routine breast cancer chemotherapy care, health education, and follow‐up;Intervention Group 1:Routine care + acupoint massage therapy;Intervention Group 2:Routine care + auricular acupressure therapy;Intervention Group 3:Routine care + combined acupoint massage and auricular acupressure; CONDITION: Chemotherapy‐Induced Peripheral Neuropathy in Breast Cancer PRIMARY OUTCOME: National Cancer Institute Common Terminology Criteria for Adverse Events (NCI‐CTCAE v5.0);Baseline® Fold‐UpTM Monofilament Evaluator, Set of 20 with Case;Chemotherapy‐Induced Peripheral Neuropathy Assessment Tool (CIPNAT); SECONDARY OUTCOME: General Information Questionnaire;European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTCQL‐C30);Grip Strength Test;Timed Up‐and‐Go (TUG) Test;Numerical Rating Scale (NRS);Traditional Chinese Medicine (TCM) Syndrome Efficacy Score;Pittsburgh Sleep Quality Inde X(PSQI); INCLUSION CRITERIA: (1) INCLUSION CRITERIA: 1) INCLUSION CRITERIA: (1. Age 18‐75 years; (2. Female patients diagnosed with breast cancer by pathological examination; (3. Patients who have not previously received neurotoxic chemotherapy and are scheduled to receive albumin‐bound paclitaxel 250 mg/m² for chemotherapy, with 21 days per cycle for a total of 4 cycles; (4. Karnofsky Performance Status Scale (KPS) score =60; (5. Expected survival period >9 months; (6. Clear consciousness, normal hearing, intact cognitive understanding ability, and able to cooperate in completing questionnaires; (7. Informed consent and voluntary participation in this study.